Selection of patients with melanoma brain metastases for aggressive treatment

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 26, Issue 4, 2003, Pages 354-357

  Harrison, Bobby E ^a   Johnson, Jeffrey L ^a   Clough, Robert W ^a   Halperin, Edward C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain metastases; Melanoma; Radiation therapy

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; PATIENT SELECTION; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CLINICAL TRIALS; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PATIENT SELECTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 0041561344     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200308000-00009     Document Type: Article

References (18)

1. Wen P, Loeffler J. Management of brain metastases. Oncology 1999;13:941-59.
2. Nieder C, Nestle U, Motaref B, et al. Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes? IJROBP 2000;46:297-302.
3. Hoskin P, Makin W. Oncology for palliative medicine. 1st ed. New York: Oxford University Press, 1998.
4. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain. JAMA 1998;280:1485-9.
5. Sampson JH, Carter JH, Friedman AH, et al. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 1998;88:11-20.
6. Sperduto PW. Preliminary Report of RTOG 9508: a phase III trial comparing whole brain irradiation alone versus whole brain irradiation plus stereotactic radiosurgery for patients with two or three unresected brain metastasis [Abstract]. ASTRO Conference Issue 2000;48:113.
7. Chougule PB. Randomized treatment of brain metastasis with gamma knife radiosurgery, whole brain radiotherapy or both [Abstract]. ASTRO Conference Issue 2000;48:114.
8. American Cancer Society. Cancerfacts and figures 2000. Atlanta, GA: American Cancer Society, 2000:4.
9. Earle KM. Metastatic and primary intracranial tumors of the adult male. J Neuropathol Exp Neurol 1954;13:448-54.
10. Chason JL, Walker FB, Landers JW. Metastatic carcinoma in the central nervous system and dorsal root ganglia: a prospective autopsy study. Cancer 1963;16:781-7.
11. Aronson SM, Garcia JH, Aronson BE. Metastatic neoplasms of the brain: their frequency in relation to age. Cancer 1964;17:558-63.
12. Posner JB, Chernik NL. Intracranial metastases from systemic cancer. Adv Neurol 1978;19:579-92.
13. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745-51.
14. Gaspar L, Scott C, Murray KJ, et al. Validation of the RTOG recursive partitioning analysis classification for brain metastases [Abstract]. Int J Radiat Oncol Biol Phys 1998;42(suppl):260.
15. Agboola O, Benoit B, Cross C, et al. Prognostic factors derived from recursive partitioning analysis (RPA) of Radiation Therapy Oncology Group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases. Int J Radiat Oncol Biol Phys 1998;42:155-9.
16. Kaplan EI, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
17. Cox DR. Regression models and life tables. J R Stat Soc Ser B 1972;34:187-220.
18. American Cancer Society. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven, 1997.